Literature DB >> 16702580

Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis.

Elisabetta Rapiti1, Helena M Verkooijen, Georges Vlastos, Gerald Fioretta, Isabelle Neyroud-Caspar, André Pascal Sappino, Pierre O Chappuis, Christine Bouchardy.   

Abstract

PURPOSE: Surgery of the primary tumor usually is not advised for patients with metastatic breast cancer at diagnosis because the disease is considered incurable. In this population-based study, we evaluate the impact of local surgery on survival of patients with metastatic breast cancer at diagnosis.
METHODS: We included all 300 metastatic breast cancer patients recorded at the Geneva Cancer Registry between 1977 and 1996. We compared mortality risks from breast cancer between patients who had surgery of the primary breast tumor to those who had not and adjusted these risks for other prognostic factors.
RESULTS: Women who had complete excision of the primary breast tumor with negative surgical margins had a 40% reduced risk of death as a result of breast cancer (multiadjusted hazard ratio [HR], 0.6; 95% CI, 0.4 to 1.0) compared with women who did not have surgery (P = .049). This mortality reduction was not significantly different among patients with different sites of metastasis, but in the stratified analysis the effect was particularly evident for women with bone metastasis only (HR, 0.2; 95% CI, 0.1 to 0.4; P = .001). Survival of women who had surgery with positive surgical margins was not different from that of women who did not have surgery.
CONCLUSION: Complete surgical excision of the primary tumor improves survival of patients with metastatic breast cancer at diagnosis, particularly among women with only bone metastases.

Entities:  

Mesh:

Year:  2006        PMID: 16702580     DOI: 10.1200/JCO.2005.04.2226

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  84 in total

1.  How do I treat "triple-negative" disease.

Authors:  Christos Vaklavas; Andres Forero-Torres
Journal:  Curr Treat Options Oncol       Date:  2011-12

2.  AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2015.

Authors:  Cornelia Liedtke; Marc Thill; Volker Hanf; Florian Schuütz
Journal:  Breast Care (Basel)       Date:  2015-06-18       Impact factor: 2.860

Review 3.  Recent developments in breast-conserving surgery for breast cancer patients.

Authors:  F Fitzal; O Riedl; R Jakesz
Journal:  Langenbecks Arch Surg       Date:  2008-09-10       Impact factor: 3.445

4.  Effect of Surgery or Radiotherapy of the Breast on Survival in Metastatic Disease: a Retrospective Cohort Study.

Authors:  Mahnaz Roayaei; Yalda Nikanpour; Hoda Mahdavi
Journal:  Indian J Surg Oncol       Date:  2019-01-05

Review 5.  Improvement of survival and prospect of cure in patients with metastatic breast cancer.

Authors:  Yee Chung Cheng; Naoto T Ueno
Journal:  Breast Cancer       Date:  2011-05-13       Impact factor: 4.239

6.  AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014.

Authors:  Volker Hanf; Florian Schütz; Cornelia Liedtke; Marc Thill
Journal:  Breast Care (Basel)       Date:  2014-07       Impact factor: 2.860

Review 7.  Primary metastatic breast cancer: the impact of locoregional therapy.

Authors:  Steffi Hartmann; Toralf Reimer; Bernd Gerber; Angrit Stachs
Journal:  Breast Care (Basel)       Date:  2014-02       Impact factor: 2.860

Review 8.  Oligometastatic breast cancer: a shift from palliative to potentially curative treatment?

Authors:  Simona Di Lascio; Olivia Pagani
Journal:  Breast Care (Basel)       Date:  2014-02       Impact factor: 2.860

Review 9.  Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression.

Authors:  Fausto Petrelli; Sandro Barni
Journal:  Med Oncol       Date:  2012-07-28       Impact factor: 3.064

10.  Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden.

Authors:  Omar M Rashid; Masayuki Nagahashi; Subramaniam Ramachandran; Laura Graham; Akimitsu Yamada; Sarah Spiegel; Harry D Bear; Kazuaki Takabe
Journal:  Surgery       Date:  2013-03-13       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.